STAT-NAT® VIROLOGY Real-Time PCR Assays

Pre-formulated real-time PCR assays for viral nucleic acid detection. Formulated with specialized master mix allowing increased sample input while maintaining high sensitivity.

Reverse transcription polymerase chain reaction assays for molecular detection of RNA viruses. The company offers RT-PCR assays including COVID-19 detection (code: COV19RNALYO.CE) with verification against emerging SARS-CoV-2 variants.

Real-time PCR assay kits for detection of human pathogens including bacteria, fungi, viruses, and parasites. Designed for clinical laboratory application.

Serology and antigen detection assays for infectious disease diagnosis. Supports testing for viral, bacterial, and parasitic infections.

Pre-formulated real-time PCR assays for bacterial pathogen detection across human diagnostics, veterinary applications, and environmental analysis. Ready-to-use assay format with optimized detection parameters.

Comprehensive immunoassay panels for detection of bacterial, viral, and parasitic pathogens. Available in multiple formats including ELISA and rapid test configurations.

Real-time qPCR diagnostic kits for in vitro nucleic acid detection and quantification. These molecular biology-based assays enable rapid pathogen identification and viral load measurement across infectious disease diagnostics. Kit components include optimized primers, probes, and reagents for accurate amplification and fluorescent detection on qPCR instruments.

Comprehensive panel of in vitro diagnostic assays for detection of multiple viral pathogens. Covers major infectious diseases requiring serological confirmation.

Vitassay qPCR Kits are quantitative PCR assays for pathogen detection in lyophilized format, enabling automated and reproducible molecular diagnostics. These kits provide rapid identification of infectious agents including viruses such as Hantavirus, with integrated controls to verify sample quality and extraction efficiency. Designed for laboratory use in clinical diagnostics and epidemiological surveillance.

A diagnostic testing solution for COVID-19 detection. The company offers PCR-based assays for SARS-CoV-2 detection, with verification against new variants such as Omicron B.1.1.529. Products include RT-PCR assays and ELISA kits for IgM monitoring of immune response in early infection stages.

SARS-CoV-2 rapid immunochromatographic assays for qualitative detection of viral infection. Available in multiple formats including test cards, cups, and dip tests for point-of-care testing in clinical and research settings. Designed for quick, accurate diagnosis to support clinical decision-making.

Real-time PCR assays for rapid detection and quantification of pathogenic microorganisms. Supports quick identification in clinical diagnostic and surveillance applications.